IP Library Granted Patent US 9,695,223
Granted Patent B2
US 9,695,223 · App. 14/719,206 · Granted Jul 4, 2017

Engineered xylose transporters with reduced glucose inhibition

Inventors: Hal Alper (Austin, TX); Eric Young (Arlington, MA); Sunmi Lee (Austin, TX)
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
C07K14/40C07K14/33A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,695,223
App. No.
14/719,206
Granted
Jul 4, 2017
Kind
B2
Abstract

Provided herein are compositions and methods useful for reducing glucose inhibition in transporting xylose, arabinose and other monosaccharides, into a yeast cell.

Claims (14)

1. A recombinant xylose transporter protein comprising a xylose transporter motif sequence and at least one glucose mitigation mutation; wherein said xylose transporter motif sequence corresponds to amino acid residue positions 36, 37, 38, 39, 40, and 41 of SEQ ID NO: 1, and wherein the xylose transporter motif comprises the sequence -G-G/F-X 1 -X 2 -X 3 -G-;

wherein,

X 1 is D, C, G, H, I, L, or F;

X 2 is A, D, C, E, G, H, or I; and

X 3 is N, C, Q, F, G, L, M, S, T, or P;

and further wherein said glucose mitigation mutation is at a position corresponding to N326, T170, I171, K155, N225, S354, A361, L407, and/or N446 of SEQ ID NO: 1 wherein the xylose transporter protein is at least 95% identical to the sequence of SEQ ID NO: 1 and has xylose transporter protein activity.

2. The recombinant xylose transporter protein of claim 1 , wherein said xylose transporter motif sequence is G-G-F-I-M-G- (SEQ ID NO:107), -G-F-F-I-M-G- (SEQ ID NO:108), -G-G-F-I-S-G- (SEQ ID NO:109), or -G-F-F-I-S-G- (SEQ ID NO: 110).

3. The recombinant xylose transporter protein of claim 1 , wherein said glucose mitigation mutation is a N326H mutation.

4. The recombinant xylose transporter protein of claim 1 , wherein said glucose mitigation mutation is a N326S mutation.

5. The recombinant xylose transporter protein of claim 1 further comprising an amino acid deletion.

6. The recombinant xylose transporter protein of claim 5 , wherein said deletion is within a protein domain corresponding to residue 497-522 of SEQ ID NO: 1.

7. A recombinant yeast cell comprising a recombinant xylose transporter protein of claim 1 .

8. The recombinant yeast cell of claim 7 , wherein the growth rate of said recombinant yeast cell in a xylose-glucose growth media is at least about 50% of the growth rate of said recombinant yeast cell in a xylose growth media.

9. A nucleic acid encoding the recombinant xylose transporter protein of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2015
From: ALPER, HAL; YOUNG, ERIC; LEE, SUNMI
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 036447/0051 →
CONFIRMATORY LICENSE Recorded Jul 10, 2015
From: UNIVERSITY OF TEXAS, AUSTIN
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 036090/0788 →
Continuity (2)
Provisional Application 62001495 · May 21, 2014
Related Publication 20150344532A1 · Dec 3, 2015